Evidence map›Paper›PMID 38613094›Full record

ReviewNutrients2024

Diet and Physical Activity in Fabry Disease: A Narrative Review.

Giovanna Muscogiuri, Oriana De Marco, Tonia Di Lorenzo, Maria Amicone, Ivana Capuano, Eleonora Riccio, Guido Iaccarino, Antonio Bianco, Teodolinda Di Risi, Antonio Pisani

Open access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Fabry Disease: A Focus on the Role of Oxidative Stress.Antioxidants (Basel, Switzerland) · 2026
    Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 2 countries.

Giovanna MuscogiuriUnità di Endocrinologia, Dipartimento di Medicina Clinica e Chirurgia, Diabetologia ed Andrologia, University of Naples Federico II, Via Sergio Pansini 5, 80131 Naples, Italy.
Oriana De MarcoChair of Nephrology "Federico II", Department of Public Health, University of Naples Federico II, Via Sergio Pansini 5, 80131 Naples, Italy.ORCID 0000-0002-8299-7160
Tonia Di LorenzoEndocrinology Unit, Centro Italiano per la Cura e il Benessere del Paziente con Obesità (C.I.B.O), Department of Clinical Medicine and Surgery, University Medical School of Naples, Via Sergio Pansini 5, 80131 Naples, Italy.
Maria AmiconeChair of Nephrology "Federico II", Department of Public Health, University of Naples Federico II, Via Sergio Pansini 5, 80131 Naples, Italy.
Ivana CapuanoChair of Nephrology "Federico II", Department of Public Health, University of Naples Federico II, Via Sergio Pansini 5, 80131 Naples, Italy.ORCID 0000-0002-6559-196X
Eleonora RiccioInstitute for Biomedical Research and Innovation, National Research Council of Italy, 90146 Palermo, Italy.
Guido IaccarinoInterdepartmental Research Center for Arterial Hypertension and Associated Pathologies (CIRIAPA)-Hypertension Research Center, University of Naples "Federico II", 80131 Naples, Italy.ORCID 0000-0002-8997-835X
Antonio BiancoInterdepartmental Research Center for Arterial Hypertension and Associated Pathologies (CIRIAPA)-Hypertension Research Center, University of Naples "Federico II", 80131 Naples, Italy.
Teodolinda Di RisiChair of Nephrology "Federico II", Department of Public Health, University of Naples Federico II, Via Sergio Pansini 5, 80131 Naples, Italy.
Antonio PisaniChair of Nephrology "Federico II", Department of Public Health, University of Naples Federico II, Via Sergio Pansini 5, 80131 Naples, Italy.
Weatherford College · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fabry disease (FD) is caused by mutations in the galactosidase alpha (GLA) gene which lead to the accumulation of globotriaosylceramide (Gb-3). Enzyme replacement therapy (ERT) and oral chaperone therapy are the current pharmacological treatments for this condition. However, in the literature, there is a growing emphasis on exploring non-pharmacological therapeutic strategies to improve the quality of life of patients with FD. In particular, the nutritional approach to FD has been marginally addressed in the scientific literature, although specific dietary interventions may be useful for the management of nephropathy and gastrointestinal complications, which are often present in patients with FD. Especially in cases of confirmed diagnosis of irritable bowel syndrome (IBS), a low-FODMAP diet can represent an effective approach to improving intestinal manifestations. Furthermore, it is known that some food components, such as polyphenols, may be able to modulate some pathogenetic mechanisms underlying the disease, such as inflammation and oxidative stress. Therefore, the use of healthy dietary patterns should be encouraged in this patient group. Sports practice can be useful for patients with multi-organ involvement, particularly in cardiovascular, renal, and neurological aspects. Therefore, the aim of this review is to summarize current knowledge on the role of nutrition and physical activity in FD patients.

Indexed as

Fabry DiseaseDietExerciseHumansNutritional StatusQuality of LifeFabry diseaseFODMAPsinflammationnutritional therapyoxidative stressphysical activity

Identifiers

PMID38613094
PMCPMC11013480
OpenAlexW4393932086

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.